ArticleInternational journal of cancer2017

GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts.

Michel Bernier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.